ETIG Analysis: Pharma companies involved in rolling out Covid-19 treatments face ESG implications
Posted by
www.biotecnika.org
Moody's Investor Services said in a report last week that the ongoing
Covid-19 vaccine development globally comes with both positives as
well as negatives for pharma companies.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/etig-analysis-pharma-companies-involved-in-rolling-out-covid-19-treatments-face-esg-implications/articleshow/76971581.cms
Subscribe to:
Post Comments (Atom)
Post a Comment